Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing and treating postnatal deep venous thrombosis of lower limbs

A technology of deep vein thrombosis and composition, applied in the field of medicine, can solve the problems of difficulty in popularization and use, large side effects, narrow treatment range and the like

Inactive Publication Date: 2016-06-15
朱效慧
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the clinical treatment of Western medicine mainly uses traditional anticoagulant drugs, such as heparin and warfarin. Heparin is administered parenterally, with many contraindications and severe side effects; Regular monitoring of blood coagulation function; although the new anticoagulant drug rivaroxaban is convenient to take and has a rapid onset of effect, it does not need to monitor blood coagulation function, but it is expensive and difficult to be widely used, and the puerpera belongs to a special population, so it should be used with caution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1 Granules

[0024] The raw materials of the present invention are weighed according to the following parts by weight: 6 parts of Codonopsis pilosula, 10 parts of Chinese jujube, 4 parts of cinnamon, 9 parts of Corydalis Corydalis, 6 parts of peach kernel, 10 parts of coix seed, 10 parts of coriander hawthorn, and 9 parts of Caulis Spatholobus.

[0025] The preparation process is as follows: take the above raw materials by weight and pulverize them into coarse powder respectively; add 6-8 times the amount of water of the total mass of the medicinal materials, warm soak for 3 hours, decoct twice for 2 hours each time, combine the decoction liquid, Filtration; when the filtrate is concentrated to 60°C, the clear paste with a relative density of 1.11 to 1.15 is dried, crushed, and appropriate amount of auxiliary materials are added to prepare granules according to conventional processes.

[0026] When using the pharmaceutical composition of the present invention...

Embodiment 2

[0027] Embodiment 2 Granules

[0028] The raw materials of the present invention are weighed according to the following parts by weight: 5 parts of Codonopsis pilosula, 8 parts of Chinese jujube, 3 parts of cinnamon, 8 parts of Corydalis Corydalis, 5 parts of peach kernel, 8 parts of coix seed, 8 parts of coriander hawthorn, and 8 parts of Caulis Spatholobus.

[0029] The preparation process is the same as in Example 1.

[0030] When using the pharmaceutical composition of the present invention to prevent and treat postpartum lower extremity deep vein thrombosis, take the prepared granules, each bag contains 3g of crude drug, 2 times a day, 1 bag each time, take half an hour after meals.

Embodiment 3

[0031] Embodiment 3 granules

[0032] The raw materials of the present invention are weighed according to the following parts by weight: 7 parts of Codonopsis pilosula, 12 parts of Chinese jujube, 5 parts of cinnamon, 10 parts of Corydalis Corydalis, 7 parts of peach kernel, 12 parts of coix seed, 12 parts of coriander hawthorn, and 10 parts of Millet Spatholobus.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines and particularly relates to a pharmaceutical composition for preventing and treating postnatal deep venous thrombosis of lower limbs. The pharmaceutical composition contains the following raw pharmaceutical materials: radix codonopsis pilosulae, fructus ziziphi jujubae, cinnamomum cassia, corydalis tuber, peach kernels, coix seeds, parched hawthorn fruits and spatholobus suberectus. According to the pharmaceutical composition provided by the invention, drug administration is carried out in an analyzing and differentiating manner, the prescription is simple, the treatment effect is definite, and the preparation is easy; through jointly using all the medicines, the pharmaceutical composition has the remarkable treatment effects of clearing away heat and eliminating dampness, promoting Qi circulation and dissipating blood stasis and promoting blood circulation and dredging collaterals; the pharmaceutical composition is an effective medicine for preventing and treating the postnatal deep venous thrombosis of the lower limbs and has remarkable significance in clinical popularization.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for preventing and treating postpartum deep vein thrombosis of lower limbs. Background technique [0002] Deep venous thrombosis is an acute non-suppurative inflammation of the deep venous lumen, accompanied by thrombosis and venous reflux disorder, and is a common peripheral vascular disease, which occurs frequently in the lower extremities. Modern medicine believes that deep vein thrombosis has three major factors: venous blood flow sluggishness, venous wall damage, and blood hypercoagulability, of which venous blood flow sluggishness and blood hypercoagulability are the two main reasons. The blood of women is in a hypercoagulable state during pregnancy and early puerperium, and the blood flow is slow due to blood loss, dehydration, blood concentration, and long-term bed rest after the operation, combined with pathological pregnancy con...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8994A61P7/02A61P9/14
CPCA61K36/344A61K36/486A61K36/54A61K36/66A61K36/725A61K36/734A61K36/736A61K36/8994A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 朱效慧
Owner 朱效慧
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com